Literature DB >> 22158434

Pyridoxamine, advanced glycation inhibition, and diabetic nephropathy.

Joline L T Chen, Jean Francis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22158434     DOI： 10.1681/ASN.2011111097

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  5 in total

1.  AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

Authors:  Ali Dehnad; Weiguo Fan; Joy X Jiang; Sarah R Fish; Yuan Li; Suvarthi Das; Gergely Mozes; Kimberly A Wong; Kristin A Olson; Gregory W Charville; Mohammed Ali; Natalie J Török
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.

Authors:  Isha Sharma; Rashmi S Tupe; Aryana K Wallner; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-20

Review 3.  Diabetic Kidney Disease: Challenges, Advances, and Opportunities.

Authors:  Ya Chen; Kyung Lee; Zhaohui Ni; John Cijiang He
Journal:  Kidney Dis (Basel)       Date:  2020-03-31

Review 4.  Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.

Authors:  Devang M Patel; Madhura Bose; Mark E Cooper
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

5.  Pyridoxamine: another vitamin for sickle cell disease?

Authors:  Marilyn J Telen
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.